EXTERNAL DEFIBRILLATORS MARKET OVERVIEW 2023-2028

The global external defibrillators market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.02% during 2023-2028.

External defibrillators are medical devices designed for administering an electric shock to the heart to restore its regular rhythm during life-threatening cardiac arrhythmias, particularly in cases of ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT). These devices are purpose-built for use in non-hospital settings, targeting individuals who may not possess advanced medical knowledge. They consist of a portable device equipped with adhesive electrode pads that are applied to the chest of a person experiencing sudden cardiac arrest (SCA).

External Defibrillators Market Trends And Drivers:

The global demand for external defibrillators is on the rise, primarily driven by several factors. One significant driver is the increasing incidence of Sudden Cardiac Arrest (SCA) in individuals, attributed to sedentary lifestyles, higher alcohol consumption, and unhealthy eating habits. Furthermore, the aging population, which is more susceptible to such medical emergencies, and substantial enhancements in healthcare infrastructure, contribute to a positive outlook for the market. Additionally, the market is benefiting from the expanding use of external defibrillators in various public settings, including sports arenas, shopping malls, airports, airplanes, businesses, convention centers, hotels, schools, and offices. This widespread adoption supports the growth of the market by ensuring broader accessibility to these life-saving devices. Moreover, the introduction of advanced external defibrillators that are cost-effective, user-friendly, and safe further accelerates the expansion of the market.

Global External Defibrillators Market 2023-2028 Analysis And Segmentation:

Top Key Players covered in this report are: BPL Medical Technologies Private Limited, corpuls, CU Medical Germany GmbH, Defibtech LLC, Koninklijke Philips N.V., MEDIANA Co. Ltd., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Stryker Corporation and ZOLL Medical Corporation (Asahi Kasei Corporation)

The report has segmented the market on the basis of region, product type and end user.

Breakup by Product Type:

  • Manual External Defibrillator
  • Automated External Defibrillator
    • Semi-Automated External Defibrillator
    • Fully Automated Defibrillator
  • Wearable Cardioverter Defibrillator

Breakup by End User:

  • Hospitals
  • Pre-Hospitals
  • Public Access Market
  • Alternate Care Market
  • Home Healthcare

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

KEY HIGHLIGHTS OF THE REPORT:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800